First dry-powder formulation of treprostinil to meet criteria required for FDA approval Final FDA approval may occur in October 2022 or earlier upon resolution of on-going litigation MORRISVILLE, N.C., Nov. 08, 2021 (GLOBE NEWSWIRE) –…Original Article
FDA Grants Tentative Approval for Liquidia’s Yutrepia (treprostinil) Inhalation Powder
